Transenterix Inc (NASDAQ:TRXC) shares were up 8% during mid-day trading on Monday . The company traded as high as $1.14 and last traded at $1.21. Approximately 2,079,179 shares changed hands during mid-day trading, an increase of 87% from the average daily volume of 1,110,970 shares. The stock had previously closed at $1.12.
A number of research analysts have recently issued reports on TRXC shares. Zacks Investment Research upgraded shares of Transenterix from a “hold” rating to a “buy” rating and set a $0.75 price target on the stock in a research report on Thursday, July 13th. B. Riley downgraded shares of Transenterix to a “neutral” rating and set a $0.70 price target on the stock. in a research report on Tuesday, May 16th.
The stock’s market cap is $170.07 million. The stock has a 50-day moving average price of $0.78 and a 200 day moving average price of $0.83.
Several large investors have recently added to or reduced their stakes in TRXC. Global X Management Co. LLC boosted its stake in shares of Transenterix by 238.3% during the second quarter. Global X Management Co. LLC now owns 331,075 shares of the company’s stock valued at $235,000 after purchasing an additional 233,213 shares during the period. LMR Partners LLP purchased a new stake in shares of Transenterix during the second quarter valued at approximately $189,000. UBS Oconnor LLC purchased a new stake in shares of Transenterix during the second quarter valued at approximately $390,000. Goldman Sachs Group Inc. boosted its stake in shares of Transenterix by 7,137.7% during the second quarter. Goldman Sachs Group Inc. now owns 1,203,199 shares of the company’s stock valued at $854,000 after purchasing an additional 1,186,575 shares during the period. Finally, Royal Bank of Canada boosted its stake in shares of Transenterix by 17.1% during the second quarter. Royal Bank of Canada now owns 418,867 shares of the company’s stock valued at $298,000 after purchasing an additional 61,034 shares during the period.
COPYRIGHT VIOLATION NOTICE: This piece was first reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this piece on another site, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The legal version of this piece can be viewed at https://sportsperspectives.com/2017/09/11/transenterix-inc-trxc-trading-up-8.html.
Transenterix Company Profile
TransEnterix, Inc is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), and SurgiBot System. The Company’s ALF-X System is a multi-port robotic surgery system, which allows multiple robotic arms to control instruments and a camera.
Receive News & Ratings for Transenterix Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transenterix Inc and related companies with MarketBeat.com's FREE daily email newsletter.